Allurion Technologies Inc. (ALUR)
NYSE NYSE Primary Summary
ALUR Chart
4 Medical Product Stocks to Watch From a Challenging Industry
The U.S. government's tariff imposition, especially on China, is likely to keep supply chains under pressure for the Zacks Medical Products industry. PODD, MGNX, CLRB and ALUR reflect the favorable fundamentals.
Allurion Technologies Inc. (ALUR) Q1 2025 Earnings Call Transcript
Allurion Technologies Inc. (NYSE:ALUR ) Q1 2025 Earnings Conference Call May 14, 2025 8:30 AM ET Company Participants Tara Brady - Interim CFO Shantanu Gaur - Founder and CEO Conference Call Participants Jason Wittes - ROTH Capital Partners Josh Jennings - TD Cowen Keay Nakae - Chardan Capital Mike Toomey - Jefferies Operator Hello, everyone, and welcome to Allurion First Quarter Earnings Call. All lines have been placed on mute to prevent any background noise.
Allurion Technologies, Inc. (ALUR) Q1 Earnings Beat Estimates
Allurion Technologies, Inc. (ALUR) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of a loss of $1.53 per share. This compares to earnings of $2.75 per share a year ago.
Allurion Technologies Inc. Dividends
Allurion Technologies Inc. Earnings
| 14 May 2025 Date | | - Cons. EPS | - EPS |
| 26 Mar 2025 Date | | - Cons. EPS | - EPS |
| 13 Nov 2024 Date | | - Cons. EPS | - EPS |
| 11 Nov 2024 Date | | - Cons. EPS | - EPS |
| 13 Aug 2024 Date | | - Cons. EPS | - EPS |
| 14 May 2025 Date | | - Cons. EPS | - EPS |
| 26 Mar 2025 Date | | - Cons. EPS | - EPS |
| 13 Nov 2024 Date | | - Cons. EPS | - EPS |
| 11 Nov 2024 Date | | - Cons. EPS | - EPS |
| 13 Aug 2024 Date | | - Cons. EPS | - EPS |
Allurion Technologies Inc. (ALUR) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Allurion Technologies Inc. ever had a stock split?
Allurion Technologies Inc. Profile
| Medical - Devices Industry | Healthcare Sector | Dr. Shantanu K. Gaur M.D. CEO | NYSE Exchange | 02008G102 Cusip |
| US Country | 134 Employees | - Last Dividend | 3 Jan 2025 Last Split | - IPO Date |
Overview
Allurion Technologies Inc. is a healthcare company dedicated to combating obesity through an innovative weight loss platform aimed at treating individuals who are overweight. With its headquarters in Natick, Massachusetts, Allurion Technologies pioneers in offering an alternative solution to traditional, invasive weight loss procedures. This approach is centered around a holistic program that integrates a unique product—the Allurion Balloon—with a comprehensive suite of digital and telehealth services designed to support patients' weight loss journeys effectively and sustainably.
Products and Services
- The Allurion Balloon
A centerpiece of the Allurion Program, this swallowable and procedure-less intragastric balloon is designed to facilitate weight loss. Unlike surgical alternatives, the Allurion Balloon is a non-invasive device that temporarily resides in the stomach, creating a feeling of fullness, which helps reduce food intake. This innovative approach allows for weight loss without the need for surgery, offering a less intimidating solution for those seeking to lose weight.
- Allurion Virtual Care Suite
Alongside the Allurion Balloon, Allurion Technologies introduces a comprehensive digital health ecosystem to support patients throughout their weight loss journey. This suite includes AI-powered remote patient monitoring tools that allow for personalized and adaptive weight loss plans, a proprietary behavior change program designed to help individuals adopt healthier lifestyle practices, secure messaging for direct communication with healthcare providers, and video telehealth services for convenient access to professional guidance and support. This integrated, patient-centered platform leverages modern technology to enhance the efficacy of the Allurion Program, paving the way for a more engaged, informed, and successful weight management experience.
Contact Information
